TW449478B - Pharmaceutical compositions for healing and repair of connective tissue attachment - Google Patents

Pharmaceutical compositions for healing and repair of connective tissue attachment Download PDF

Info

Publication number: TW449478B
Authority: TW; Taiwan
Prior art keywords: bone; bmp; patent application; carrier; tendon
Prior art date: 1995-06-05

Application number

TW085106195A

Other languages

English (en)

Chinese (zh)

Inventor

John M Wozney

Russel F Warren

Scott A Rodeo

Jo A Hannafin

Original Assignee

Genetics Inst

New York Soc For Relief Of The

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-05

Filing date

1996-05-24

Publication date

2001-08-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23836637&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW449478(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-05-24 Application filed by Genetics Inst, New York Soc For Relief Of The filed Critical Genetics Inst

2001-08-11 Application granted granted Critical

2001-08-11 Publication of TW449478B publication Critical patent/TW449478B/zh

Links

210000002808 connective tissue Anatomy 0.000 title claims abstract description 25
230000035876 healing Effects 0.000 title claims description 11
239000008194 pharmaceutical composition Substances 0.000 title claims 5
230000008439 repair process Effects 0.000 title description 10
210000000988 bone and bone Anatomy 0.000 claims abstract description 88
210000002435 tendon Anatomy 0.000 claims abstract description 50
239000000203 mixture Substances 0.000 claims abstract description 35
210000001519 tissue Anatomy 0.000 claims abstract description 21
230000008929 regeneration Effects 0.000 claims abstract description 15
238000011069 regeneration method Methods 0.000 claims abstract description 15
102000004169 proteins and genes Human genes 0.000 claims description 45
108090000623 proteins and genes Proteins 0.000 claims description 45
239000000515 collagen sponge Substances 0.000 claims description 17
108010049931 Bone Morphogenetic Protein 2 Proteins 0.000 claims description 15
102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims description 15
102000008186 Collagen Human genes 0.000 claims description 15
108010035532 Collagen Proteins 0.000 claims description 15
229920001436 collagen Polymers 0.000 claims description 14
229920000642 polymer Polymers 0.000 claims description 14
239000000126 substance Substances 0.000 claims description 10
238000001356 surgical procedure Methods 0.000 claims description 10
239000001913 cellulose Substances 0.000 claims description 9
229920002678 cellulose Polymers 0.000 claims description 9
230000002079 cooperative effect Effects 0.000 claims description 6
230000006378 damage Effects 0.000 claims description 6
230000015572 biosynthetic process Effects 0.000 claims description 5
239000003795 chemical substances by application Substances 0.000 claims description 5
101150061927 BMP2 gene Proteins 0.000 claims description 4
239000008280 blood Substances 0.000 claims description 4
210000004369 blood Anatomy 0.000 claims description 4
230000012010 growth Effects 0.000 claims description 4
238000000926 separation method Methods 0.000 claims description 4
101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 claims description 3
102000045896 human BMP2 Human genes 0.000 claims description 3
230000001939 inductive effect Effects 0.000 claims description 3
230000001582 osteoblastic effect Effects 0.000 claims description 2
230000004221 bone function Effects 0.000 claims 1
230000001568 sexual effect Effects 0.000 claims 1
238000000034 method Methods 0.000 abstract description 27
210000003041 ligament Anatomy 0.000 abstract description 12
230000001965 increasing effect Effects 0.000 abstract description 6
238000002278 reconstructive surgery Methods 0.000 abstract description 4
201000010099 disease Diseases 0.000 abstract description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
102000007350 Bone Morphogenetic Proteins Human genes 0.000 abstract 1
108010007726 Bone Morphogenetic Proteins Proteins 0.000 abstract 1
206010063560 Excessive granulation tissue Diseases 0.000 abstract 1
230000003190 augmentative effect Effects 0.000 abstract 1
229940112869 bone morphogenetic protein Drugs 0.000 abstract 1
230000007547 defect Effects 0.000 abstract 1
210000001126 granulation tissue Anatomy 0.000 abstract 1
235000018102 proteins Nutrition 0.000 description 41
230000002188 osteogenic effect Effects 0.000 description 13
210000003414 extremity Anatomy 0.000 description 12
210000003127 knee Anatomy 0.000 description 11
210000002303 tibia Anatomy 0.000 description 6
210000004027 cell Anatomy 0.000 description 5
239000000835 fiber Substances 0.000 description 5
210000003811 finger Anatomy 0.000 description 5
210000004417 patella Anatomy 0.000 description 5
210000005239 tubule Anatomy 0.000 description 5
241000282472 Canis lupus familiaris Species 0.000 description 4
239000000463 material Substances 0.000 description 4
241000894007 species Species 0.000 description 4
229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
230000008901 benefit Effects 0.000 description 3
239000001768 carboxy methyl cellulose Substances 0.000 description 3
235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
239000008112 carboxymethyl-cellulose Substances 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000000499 gel Substances 0.000 description 3
210000003205 muscle Anatomy 0.000 description 3
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
108090000654 Bone morphogenetic protein 1 Proteins 0.000 description 2
102100028728 Bone morphogenetic protein 1 Human genes 0.000 description 2
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
108091027305 Heteroduplex Proteins 0.000 description 2
239000002202 Polyethylene glycol Substances 0.000 description 2
210000003423 ankle Anatomy 0.000 description 2
210000001264 anterior cruciate ligament Anatomy 0.000 description 2
230000033558 biomineral tissue development Effects 0.000 description 2
239000000872 buffer Substances 0.000 description 2
239000000512 collagen gel Substances 0.000 description 2
230000003412 degenerative effect Effects 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
210000003195 fascia Anatomy 0.000 description 2
238000009472 formulation Methods 0.000 description 2
229920002674 hyaluronan Polymers 0.000 description 2
229960003160 hyaluronic acid Drugs 0.000 description 2
210000000629 knee joint Anatomy 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000000178 monomer Substances 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
-1 polyoxyethylene, carboxyvinyl Polymers 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
230000000750 progressive effect Effects 0.000 description 2
235000015170 shellfish Nutrition 0.000 description 2
210000002832 shoulder Anatomy 0.000 description 2
239000000243 solution Substances 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
238000012360 testing method Methods 0.000 description 2
210000004885 white matter Anatomy 0.000 description 2
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
101150072730 Bmp6 gene Proteins 0.000 description 1
108010049955 Bone Morphogenetic Protein 4 Proteins 0.000 description 1
108010049976 Bone Morphogenetic Protein 5 Proteins 0.000 description 1
108010049974 Bone Morphogenetic Protein 6 Proteins 0.000 description 1
108010049870 Bone Morphogenetic Protein 7 Proteins 0.000 description 1
102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
102100022526 Bone morphogenetic protein 5 Human genes 0.000 description 1
102100022525 Bone morphogenetic protein 6 Human genes 0.000 description 1
102100022544 Bone morphogenetic protein 7 Human genes 0.000 description 1
102100022545 Bone morphogenetic protein 8B Human genes 0.000 description 1
102000012422 Collagen Type I Human genes 0.000 description 1
108010022452 Collagen Type I Proteins 0.000 description 1
208000027205 Congenital disease Diseases 0.000 description 1
239000001856 Ethyl cellulose Substances 0.000 description 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
206010016654 Fibrosis Diseases 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
108010090290 Growth Differentiation Factor 2 Proteins 0.000 description 1
102100040892 Growth/differentiation factor 2 Human genes 0.000 description 1
102100035368 Growth/differentiation factor 6 Human genes 0.000 description 1
101710204281 Growth/differentiation factor 6 Proteins 0.000 description 1
101000899368 Homo sapiens Bone morphogenetic protein 8B Proteins 0.000 description 1
229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
206010065433 Ligament rupture Diseases 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
238000000692 Student's t-test Methods 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
206010060872 Transplant failure Diseases 0.000 description 1
230000002411 adverse Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
150000001345 alkine derivatives Chemical class 0.000 description 1
229920013820 alkyl cellulose Polymers 0.000 description 1
150000001409 amidines Chemical class 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
229910052586 apatite Inorganic materials 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000014461 bone development Effects 0.000 description 1
230000008468 bone growth Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
239000000969 carrier Substances 0.000 description 1
210000000845 cartilage Anatomy 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
229910052804 chromium Inorganic materials 0.000 description 1
239000011651 chromium Substances 0.000 description 1
210000004439 collateral ligament Anatomy 0.000 description 1
229920000891 common polymer Polymers 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
230000007850 degeneration Effects 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
238000002224 dissection Methods 0.000 description 1
210000001513 elbow Anatomy 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
229920001249 ethyl cellulose Polymers 0.000 description 1
235000019325 ethyl cellulose Nutrition 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
230000004761 fibrosis Effects 0.000 description 1
238000000799 fluorescence microscopy Methods 0.000 description 1
210000002683 foot Anatomy 0.000 description 1
230000004927 fusion Effects 0.000 description 1
LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
229960002449 glycine Drugs 0.000 description 1
235000013905 glycine and its sodium salt Nutrition 0.000 description 1
210000004247 hand Anatomy 0.000 description 1
239000000833 heterodimer Substances 0.000 description 1
210000002758 humerus Anatomy 0.000 description 1
125000002768 hydroxyalkyl group Chemical group 0.000 description 1
235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
239000001863 hydroxypropyl cellulose Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000008595 infiltration Effects 0.000 description 1
238000001764 infiltration Methods 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
208000014674 injury Diseases 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
238000011835 investigation Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
210000002414 leg Anatomy 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000010297 mechanical methods and process Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
235000010981 methylcellulose Nutrition 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
239000011707 mineral Substances 0.000 description 1
208000015122 neurodegenerative disease Diseases 0.000 description 1
239000002736 nonionic surfactant Substances 0.000 description 1
210000000963 osteoblast Anatomy 0.000 description 1
210000003254 palate Anatomy 0.000 description 1
206010033675 panniculitis Diseases 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
229940068968 polysorbate 80 Drugs 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
229910052704 radon Inorganic materials 0.000 description 1
SYUHGPGVQRZVTB-UHFFFAOYSA-N radon atom Chemical compound [Rn] SYUHGPGVQRZVTB-UHFFFAOYSA-N 0.000 description 1
230000007420 reactivation Effects 0.000 description 1
238000012079 reconstructive surgical procedure Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
239000012925 reference material Substances 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
210000001991 scapula Anatomy 0.000 description 1
235000010413 sodium alginate Nutrition 0.000 description 1
239000000661 sodium alginate Substances 0.000 description 1
229940005550 sodium alginate Drugs 0.000 description 1
210000004304 subcutaneous tissue Anatomy 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000012353 t test Methods 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
210000003813 thumb Anatomy 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
230000008733 trauma Effects 0.000 description 1
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
210000000623 ulna Anatomy 0.000 description 1
210000000689 upper leg Anatomy 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/10—Materials or treatment for tissue regeneration for reconstruction of tendons or ligaments

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Dispersion Chemistry (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Physical Education & Sports Medicine (AREA)
Materials For Medical Uses (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Prostheses (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Dental Preparations (AREA)
Peptides Or Proteins (AREA)

TW085106195A 1995-06-05 1996-05-24 Pharmaceutical compositions for healing and repair of connective tissue attachment TW449478B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US46249795A	1995-06-05	1995-06-05

Publications (1)

Publication Number	Publication Date
TW449478B true TW449478B (en)	2001-08-11

Family

ID=23836637

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW085106195A TW449478B (en)	1995-06-05	1996-05-24	Pharmaceutical compositions for healing and repair of connective tissue attachment

Country Status (17)

Country	Link
US (1)	US6187742B1 (2)
EP (3)	EP2289536A1 (2)
JP (1)	JPH11507032A (2)
KR (1)	KR100440645B1 (2)
CN (1)	CN1133462C (2)
AT (1)	ATE245996T1 (2)
AU (1)	AU699918B2 (2)
CA (1)	CA2220555C (2)
DE (1)	DE69629294T2 (2)
DK (2)	DK0831884T3 (2)
ES (2)	ES2203701T3 (2)
FI (1)	FI116511B (2)
HU (1)	HU222664B1 (2)
OA (1)	OA10547A (2)
PT (1)	PT831884E (2)
TW (1)	TW449478B (2)
WO (1)	WO1996039169A1 (2)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6150328A (en)	1986-07-01	2000-11-21	Genetics Institute, Inc.	BMP products
ATE238417T1 (de) *	1991-11-04	2003-05-15	Inst Genetics Llc	Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
US20080139474A1 (en) *	1991-11-04	2008-06-12	David Israel	Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
US6291206B1 (en)	1993-09-17	2001-09-18	Genetics Institute, Inc.	BMP receptor proteins
DE69434651T2 (de)	1993-12-07	2007-03-08	Genetics Institute, Inc., Cambridge	Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
US5906827A (en) *	1994-06-03	1999-05-25	Creative Biomolecules, Inc.	Matrix for the manufacture of autogenous replacement body parts
AU6021598A (en)	1997-01-09	1998-08-03	Cohesion Technologies, Inc.	Methods and apparatuses for making swellable uniformly shaped devices from polymeric materials
EP0957943B2 (en) †	1997-02-07	2008-11-26	Stryker Corporation	Matrix-free osteogenic devices, implants and methods of use thereof
US7041641B2 (en)	1997-03-20	2006-05-09	Stryker Corporation	Osteogenic devices and methods of use thereof for repair of endochondral bone and osteochondral defects
US20010016646A1 (en)	1998-03-20	2001-08-23	David C. Rueger	Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects
CN1068793C (zh) *	1997-04-17	2001-07-25	中国人民解放军第四军医大学全军创伤骨科研究所	骨生长刺激素注射剂及其制备方法
EP0896825B1 (en)	1997-08-14	2002-07-17	Sulzer Innotec Ag	Composition and device for in vivo cartilage repair comprising nanocapsules with osteoinductive and/or chondroinductive factors
US6727224B1 (en)	1999-02-01	2004-04-27	Genetics Institute, Llc.	Methods and compositions for healing and repair of articular cartilage
PT1223990E (pt)	1999-10-15	2004-12-31	Fidia Advanced Biopolymers Srl	Formulacoes de acido hialuronico para administracao de proteinas osteogenicas
US6632246B1 (en)	2000-03-14	2003-10-14	Chondrosite, Llc	Cartilage repair plug
US6626945B2 (en)	2000-03-14	2003-09-30	Chondrosite, Llc	Cartilage repair plug
WO2001070288A2 (en) *	2000-03-23	2001-09-27	Genetics Institute, Inc.	Thermoreversible polymers for delivery and retention of osteoinductive proteins
US6878166B2 (en) *	2000-08-28	2005-04-12	Ron Clark	Method and implant for securing ligament replacement into the knee
US20030082233A1 (en) *	2000-12-01	2003-05-01	Lyons Karen M.	Method and composition for modulating bone growth
US20020114795A1 (en) *	2000-12-22	2002-08-22	Thorne Kevin J.	Composition and process for bone growth and repair
EP1399023B1 (en)	2001-06-01	2008-04-30	Wyeth	COMPOSITIONS FOR SYSTEMIC ADMINISTRATION OF SEQUENCES ENCODING BONE MORPHOGENETIC PROTEINS& x9;
TWI267378B (en)	2001-06-08	2006-12-01	Wyeth Corp	Calcium phosphate delivery vehicles for osteoinductive proteins
ATE303169T1 (de)	2001-11-19	2005-09-15	Scil Technology Gmbh	Homogen beschichtete vorrichtung mit osteoinduktiven und osteokonduktiven eigenschaften
JP4614661B2 (ja) *	2002-02-08	2011-01-19	ワイス	生体活性因子を含有する処方物およびそれを使用する方法
BR0310087A (pt) *	2002-05-17	2005-08-16	Wyeth Corp	Veìculos sólidos injetáveis para ácido hialurÈnico para aplicação de proteìnas osteogênicas
US7622562B2 (en) *	2002-06-26	2009-11-24	Zimmer Orthobiologics, Inc.	Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
AU2003253049A1 (en) *	2002-09-10	2004-04-30	Scil Technology Gmbh	Metal implant coated under reduced oxygen concentration with osteoinductive protein
AU2004272072B2 (en)	2003-09-12	2010-07-08	Etex Corporation	Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
US7896917B2 (en) *	2003-10-15	2011-03-01	Biomet Sports Medicine, Llc	Method and apparatus for graft fixation
US7767221B2 (en) *	2004-03-05	2010-08-03	The Trustees Of Columbia University In The City Of New York	Multi-phased, biodegradable and osteointegrative composite scaffold for biological fixation of musculoskeletal soft tissue to bone
US8002778B1 (en)	2004-06-28	2011-08-23	Biomet Sports Medicine, Llc	Crosspin and method for inserting the same during soft ligament repair
WO2006081379A1 (en) *	2005-01-26	2006-08-03	Wyeth	Use of sfrps as markers of bmp activity
US20060239951A1 (en) *	2005-03-30	2006-10-26	Alexandre Valentin	Methods for stimulating hair growth by administering BMPs
US20060287675A1 (en) *	2005-06-15	2006-12-21	Prajapati Rita T	Method of intra-operative coating therapeutic agents onto sutures composite sutures and methods of use
US20060286289A1 (en) *	2005-06-15	2006-12-21	Rita Prajapati	Method of intraoperative coating therapeutic agents onto sutures
US20060287676A1 (en) *	2005-06-15	2006-12-21	Rita Prajapati	Method of intra-operative coating therapeutic agents onto sutures, composite sutures and methods of use
US20100047309A1 (en) *	2006-12-06	2010-02-25	Lu Helen H	Graft collar and scaffold apparatuses for musculoskeletal tissue engineering and related methods
AU2007234612B2 (en)	2006-12-14	2013-06-27	Johnson & Johnson Regenerative Therapeutics, Llc	Protein stabilization formulations
US7718616B2 (en)	2006-12-21	2010-05-18	Zimmer Orthobiologics, Inc.	Bone growth particles and osteoinductive composition thereof
US8753391B2 (en)	2007-02-12	2014-06-17	The Trustees Of Columbia University In The City Of New York	Fully synthetic implantable multi-phased scaffold
US8147546B2 (en) *	2007-03-13	2012-04-03	Biomet Sports Medicine, Llc	Method and apparatus for graft fixation
US8075562B2 (en) *	2007-06-25	2011-12-13	Wisconsin Alumni Research Foundation	Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery
US7678764B2 (en)	2007-06-29	2010-03-16	Johnson & Johnson Regenerative Therapeutics, Llc	Protein formulations for use at elevated temperatures
CN101801405A (zh)	2007-08-07	2010-08-11	先进科技及再生医学有限责任公司	包含于酸性水溶液中的gdf-5的蛋白质配方
BRPI0911048A2 (pt) *	2008-04-14	2015-12-29	Atrm Llc	formulações líquidas tamponadas de gdf-5
CA2806143A1 (en)	2010-07-30	2012-02-02	Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mb H	Drug delivery devices and growth factor formulations for accelerated wound healing
AU2011329054B2 (en)	2010-11-15	2015-05-28	Zimmer Orthobiologics, Inc.	Bone void fillers
EP2537538A1 (en)	2011-06-22	2012-12-26	Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH	Bioresorbable Wound Dressing
EP2983643A4 (en)	2013-04-12	2016-12-28	Univ Columbia	PROCESS FOR HOST CELL HOMING AND TOOTH MARK GENERATION
WO2016007742A1 (en) *	2014-07-09	2016-01-14	Riester Scott M	Treating rotator cuff conditions
US10596192B2 (en)	2015-07-16	2020-03-24	Mayo Foundation For Medical Education And Research	Treating rotator cuff conditions
CN110893250B (zh) *	2019-10-11	2022-03-15	许和平	瘢痕/粘连阻挡膜及其制备方法和用途
US12310928B2 (en)	2020-11-16	2025-05-27	University Of Utah Research Foundation	Enthesis healing

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA874681B (en)	1986-07-01	1988-04-27	Genetics Inst	Novel osteoinductive factors
US5187076A (en)	1986-07-01	1993-02-16	Genetics Institute, Inc.	DNA sequences encoding BMP-6 proteins
US5108922A (en)	1986-07-01	1992-04-28	Genetics Institute, Inc.	DNA sequences encoding BMP-1 products
US5013649A (en)	1986-07-01	1991-05-07	Genetics Institute, Inc.	DNA sequences encoding osteoinductive products
IL83003A (en) *	1986-07-01	1995-07-31	Genetics Inst	Osteoinductive factors
US5106748A (en)	1986-07-01	1992-04-21	Genetics Institute, Inc.	Dna sequences encoding 5 proteins
US4877864A (en)	1987-03-26	1989-10-31	Genetics Institute, Inc.	Osteoinductive factors
US5024841A (en)	1988-06-30	1991-06-18	Collagen Corporation	Collagen wound healing matrices and process for their production
US5256418A (en)	1990-04-06	1993-10-26	Organogenesis, Inc.	Collagen constructs
JPH06500991A (ja)	1990-05-16	1994-01-27	ジェネティックス・インスティテュート・インコーポレイテッド	骨および軟骨誘導蛋白質
EP0513334A4 (en) *	1990-11-30	1993-08-04	Celtrix Laboratories, Inc.	Use of a bone morphogenetic protein in synergistic combination with tgf--g(b) for bone repair
US5206028A (en)	1991-02-11	1993-04-27	Li Shu Tung	Dense collagen membrane matrices for medical uses
WO1993000050A1 (en)	1991-06-21	1993-01-07	Genetics Institute, Inc.	Pharmaceutical formulations of osteogenic proteins
AU652472B2 (en)	1991-06-25	1994-08-25	Genetics Institute, Llc	BMP-9 compositions
US5171579A (en)	1991-10-11	1992-12-15	Genetics Institute, Inc.	Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
ATE238417T1 (de)	1991-11-04	2003-05-15	Inst Genetics Llc	Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
DK0625989T3 (da)	1992-02-12	2000-06-26	Bioph Biotech Entw Pharm Gmbh	DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
WO1994006399A1 (en) *	1992-09-15	1994-03-31	Creative Biomolecules, Inc.	Morphogen-induced periodontal tissue regeneration
JP3645258B2 (ja)	1993-01-12	2005-05-11	ジョーンズホプキンスユニバーシティースクールオブメディシン	増殖分化因子−５
EP0678101A4 (en)	1993-01-12	1997-07-16	Univ Johns Hopkins Med	FACTOR-9 OF GROWTH AND DIFFERENTIATION.
WO1994015965A1 (en)	1993-01-12	1994-07-21	Johns Hopkins University School Of Medicine	Growth differentiation factor-3
DK0690873T3 (da)	1993-03-19	2003-09-29	Univ Johns Hopkins Med	Vækstdifferentieringsfaktor-8
BR9406715A (pt)	1993-05-12	1996-02-06	Genetics Inst	Molécula de DNA isolada célula hospedeira vetor método para produzir uma proteina (BMP-11) polipeptideo de proteina-11 morfogenética de osso purificada (BMP-11) e molécula de DNA quimérica
EP0698095B1 (en)	1993-05-12	2004-04-28	Genetics Institute, LLC	Bmp-10 compositions
FR2706749B1 (fr)	1993-06-23	1995-08-25	Oreal	Brosse pour appliquer un produit de maquillage, en particulier du mascara
EP0717633A4 (en)	1993-07-09	1998-05-20	Univ Johns Hopkins Med	GROWTH DIFFERENTIATION FACTOR-7
CA2165776A1 (en)	1993-07-09	1995-01-19	The Johns Hopkins University School Of Medicine	Growth differentiation factor-6
DE69434651T2 (de) *	1993-12-07	2007-03-08	Genetics Institute, Inc., Cambridge	Bmp-12, bmp-13 und diese enthaltende sehne-induzierende zusammensetzungen
US5906827A (en) *	1994-06-03	1999-05-25	Creative Biomolecules, Inc.	Matrix for the manufacture of autogenous replacement body parts
US5635372A (en) *	1995-05-18	1997-06-03	Genetics Institute, Inc.	BMP-15 compositions

1996
- 1996-05-21 WO PCT/US1996/007282 patent/WO1996039169A1/en not_active Ceased
- 1996-05-21 AT AT96916513T patent/ATE245996T1/de active
- 1996-05-21 CN CNB961944358A patent/CN1133462C/zh not_active Expired - Lifetime
- 1996-05-21 EP EP10179024A patent/EP2289536A1/en not_active Withdrawn
- 1996-05-21 PT PT96916513T patent/PT831884E/pt unknown
- 1996-05-21 KR KR1019970708278A patent/KR100440645B1/ko not_active Expired - Lifetime
- 1996-05-21 AU AU59234/96A patent/AU699918B2/en not_active Expired
- 1996-05-21 HU HU9802556A patent/HU222664B1/hu active IP Right Grant
- 1996-05-21 DE DE69629294T patent/DE69629294T2/de not_active Revoked
- 1996-05-21 DK DK96916513T patent/DK0831884T3/da active
- 1996-05-21 DK DK03015894.3T patent/DK1364656T3/da active
- 1996-05-21 ES ES96916513T patent/ES2203701T3/es not_active Expired - Lifetime
- 1996-05-21 JP JP9500616A patent/JPH11507032A/ja not_active Withdrawn
- 1996-05-21 ES ES03015894.3T patent/ES2440441T3/es not_active Expired - Lifetime
- 1996-05-21 EP EP96916513A patent/EP0831884B1/en not_active Revoked
- 1996-05-21 CA CA2220555A patent/CA2220555C/en not_active Expired - Lifetime
- 1996-05-21 EP EP03015894.3A patent/EP1364656B1/en not_active Expired - Lifetime
- 1996-05-24 TW TW085106195A patent/TW449478B/zh not_active IP Right Cessation
1997
- 1997-12-02 FI FI974395A patent/FI116511B/fi not_active IP Right Cessation
- 1997-12-05 OA OA70152A patent/OA10547A/en unknown
1999
- 1999-03-23 US US09/274,575 patent/US6187742B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
HUP9802556A1 (hu)	1999-03-29
ES2440441T3 (es)	2014-01-29
AU5923496A (en)	1996-12-24
CA2220555C (en)	2011-07-19
KR100440645B1 (ko)	2004-09-18
ES2203701T3 (es)	2004-04-16
FI116511B (fi)	2005-12-15
DE69629294T2 (de)	2004-04-29
DK1364656T3 (da)	2013-12-16
EP0831884B1 (en)	2003-07-30
HUP9802556A3 (en)	1999-04-28
JPH11507032A (ja)	1999-06-22
AU699918B2 (en)	1998-12-17
CA2220555A1 (en)	1996-12-12
EP1364656B1 (en)	2013-11-20
HU222664B1 (hu)	2003-09-29
EP1364656A3 (en)	2003-12-10
US6187742B1 (en)	2001-02-13
EP1364656A2 (en)	2003-11-26
FI974395A0 (fi)	1997-12-02
EP2289536A1 (en)	2011-03-02
CN1133462C (zh)	2004-01-07
PT831884E (pt)	2003-11-28
DK0831884T3 (da)	2003-11-03
WO1996039169A1 (en)	1996-12-12
DE69629294D1 (de)	2003-09-04
KR19990014932A (ko)	1999-02-25
FI974395L (fi)	1997-12-02
EP0831884A1 (en)	1998-04-01
CN1186438A (zh)	1998-07-01
HK1017841A1 (en)	1999-12-03
OA10547A (en)	2002-05-31
ATE245996T1 (de)	2003-08-15

Legal Events

Date	Code	Title	Description
2001-12-17	GD4A	Issue of patent certificate for granted invention patent
2016-07-01	MK4A	Expiration of patent term of an invention patent

Publication	Publication Date	Title
TW449478B (en)	2001-08-11	Pharmaceutical compositions for healing and repair of connective tissue attachment
JP4477702B2 (ja)	2010-06-09	骨の修復のための骨形成デバイスおよびその使用
Wang et al.	2005	The effect of shock wave treatment at the tendon–bone interface—An histomorphological and biomechanical study in rabbits
Rodeo et al.	1999	Use of recombinant human bone morphogenetic protein-2 to enhance tendon healing in a bone tunnel
Zegzula et al.	1997	Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2)
Giannoudis et al.	2009	The synergistic effect of autograft and BMP-7 in the treatment of atrophic nonunions
Khan et al.	2000	Clinical applications of bone graft substitutes
JP4121558B2 (ja)	2008-07-23	形態形成タンパク質および刺激因子を使用する組成物および治療方法
KIRKER‐HEAD	1995	Recombinant bone morphogenetic proteins: novel substances for enhancing bone healing
CN101432030A (zh)	2009-05-13	带有一个或多个贮液器的医疗用移植物
JP2005513030A (ja)	2005-05-12	医薬組成物及びｅｐ２受容体選択的アゴニストの投与方法
Hao et al.	2016	Local injection of bone mesenchymal stem cells and fibrin glue promotes the repair of bone atrophic nonunion in vivo
WO1998031788A1 (en)	1998-07-23	Injectable formulations for treatment of osteoporotic bone
RU2727241C2 (ru)	2020-07-21	Образование кости
Hsu et al.	2014	The use of demineralized bone matrix for anterior cruciate ligament reconstruction: a radiographic, histologic, and immunohistochemical study in rabbits
Duan et al.	2008	Repair of rabbit femoral defects with a novel BMP2-derived oligopeptide P24
CN100435859C (zh)	2008-11-26	用于关节软骨愈合和修复的骨软骨移植物的制备方法和组合物
HK1017841B (en)	2004-11-26	Methods and compositions for healing and repair of connective tissue attachment
ES3028409T3 (en)	2025-06-19	A tissue sealant for use in anterior cruciate ligament (acl) reconstruction
FI20055480A7 (fi)	2005-09-06	BMP-4-, BMP-12-, BMP-13-ja MP-52-polypeptidien käyttö valmistettaessa sidekudoskiinnityksen regenerointiin tarkoitettuja farmaseuttisia koostumuksia
HK40019925B (zh)	2022-06-30	自体骨移植物替代物
Ferretti	1999	The Repair of Segmental Mandibular Defects by a Bone Morphogenetic Protein Bone Device in Man